Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients

1 Sept 1997

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Lung Cancer Research Studies
Share to Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 9389925
DOI: 10.1016/s0959-8049(97)00282-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patientsPMID 9389925Read ↗

17q gain in neuroblastoma predicts adverse clinical outcomeSemantic proximity Read ↗

Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaSemantic proximity Read ↗

Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.Semantic proximity Read ↗

17q Gain in Neuroblastoma: A Review of Clinical and Biological ImplicationsSemantic proximity Read ↗

Prognostic implications of chromosome 17p deletions in human medulloblastomasSemantic proximity Read ↗

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progressionSemantic proximity Read ↗

Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progressionSemantic proximity Read ↗

Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in NeuroblastomaSemantic proximity Read ↗

Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations.Semantic proximity Read ↗

Neuroblastoma tumour genetics: clinical and biological aspectsSemantic proximity Read ↗

Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaSemantic proximity Read ↗

Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.